Using ultrasound to assess soft tissue changes after breast cancer treatment
Official title: Reliability and Validity of Ultrasound for the Assessment of Structural and Mechanical Properties of Soft Tissues at the Upper Limb Region in Women After Breast Cancer Treatment
Run by Universiteit Antwerpen · NCT06180642 · Data updated 2026-11-12
This study tests if regular 2D ultrasound can help understand how breast cancer treatment changes soft tissue around the breast and arm in patients, especially looking at those who have or don’t have arm problems.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 90 (estimated) |
| Sponsor | Universiteit Antwerpen Academic / other |
| Locations | 1 site (Antwerp) |
| Status | Recruiting |
| Started | May 2, 2023 |
| Main results expected | May 2, 2025 |
| Study ends | May 2, 2026 |
| Registry record updated | December 11, 2024 |
| Trial ID | NCT06180642 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are breast cancer patients who have undergone specific surgical treatments and are at least three months post-surgery without upper limb dysfunctions.
✕Probably not a fit
Patients with bilateral breast surgery, widespread metastases, or upper limb dysfunctions caused by other conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate the reliability and validity of conventional 2D ultrasound in assessing soft tissue properties, such as composition and thickness, in breast cancer patients. It focuses on understanding how breast cancer treatment affects upper limb function by examining changes in the soft tissue around the breast and axilla. The study will include two groups of breast cancer patients: those without upper limb dysfunctions and those with such dysfunctions, allowing for a comprehensive analysis of the impact of treatment. Participants will undergo ultrasound assessments to gather objective data on their soft tissue properties.
Why it matters
Potential benefit: If successful, this study could lead to improved assessment and management of upper limb dysfunctions in breast cancer survivors, enhancing their quality of life.
How similar studies have gone: While the use of ultrasound in assessing soft tissue properties is established, this specific application in breast cancer treatment is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
1. Breast cancer patients without upper limb dysfunctions (n=30) Inclusion Criteria * Patients with unilateral primary breast cancer * Surgery including, either: Mastectomy with axillary lymph node dissection or sentinel lymph node biopsy or breast conserving surgery with axillary lymph node dissection or sentinel lymph node biopsy * At least 3 months after surgery or radiotherapy in order to take into account wound healing * Comprehensive of the Dutch language * QuickDASH score \<15/100 Exclusion Criteria: * Bilateral surgery, widespread distance metastases, previous breast surgery * Diagnosis of neurological or rheumatological condition * upper limb dysfunctions caused by other reasons 2. Breast cancer patients with upper limb dysfunctions (n=30) Inclusion Criteria * Patients with unilateral primary breast cancer * Surgery including, either: Mastectomy with axillary lymph node dissection or sentinel lymph node biopsy or breast conserving surgery with axillary lymph node dissection or sentinel lymph node biopsy * At least 3 months after surgery or radiotherapy in order to take into account wound healing * Comprehensive of the Dutch language * QuickDASH score \>15/100 Exclusion Criteria: * Bilateral surgery, widespread distance metastases, previous breast surgery * Diagnosis of neurological or rheumatological condition * upper limb dysfunctions caused by other reasons 3. Healthy volunteers (n=30) Inclusion criteria: * Healthy women (QuickDASH \<15) age-matched with a breast cancer patient from the main study * Comprehensive of the Dutch language Exclusion criteria: * upper limb dysfunctions * Diagnosis of neurological or rheumatological condition, diabetes
Where it's running
-
Universiteit Antwerpen
Antwerp, Belgium Recruiting
Study contacts
- Study coordinator: An De Groef, Prof.
- Email: an.degroef@uantwerpen.be
- Phone: 003216376668
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Improved Facial Skin Quality After VYC-12L for Breast Cancer Survivors
This study tests whether intradermal injections of VYC-12L can improve facial skin quality and quality of life in adults who have completed breast cancer treatment.
-
Breast cancer subtypes and outcomes in Colombian women
This study looks back at medical records of women with breast cancer to see how different molecular subtypes relate to survival and recurrence in a single Colombian hospital.
-
Multimodal psychosomatic symptom care for breast cancer: personalized acupuncture care guided by shared decision-making
This study tests whether personalized acupuncture options (manual acupuncture, ear acupuncture, or both) can help women with breast cancer who have anxiety, sleep problems, or fatigue, compared to routine nursing care.
-
Slow Jogging for Breast Cancer Survivors
This study tests whether a 12-week slow jogging program helps sleep quality in women who have completed breast cancer treatment.
-
Methylscape test in body fluids for multi-cancer detection in Colombia
A simple blood, urine, or saliva test called Methylscape is being tested to see if it can detect multiple cancers and identify where the signal is coming from, using people with cancer and healthy volunteers in Colombia.
-
Benchmarking AI language models against tumor boards for oncology treatment decisions
This project tests whether frontier AI language models can match the treatment recommendations of multidisciplinary tumor boards for common cancers using standardized synthetic cases.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.